The number of COVID-19 tests carried out in India has also crossed the 2 crore-mark, according to the Indian Council of Medical Research (ICMR).
India's COVID-19 tally crossed the 18-lakh mark on August 3, just a day after it went past 17 lakh, with 52,972 cases reported in a day while the number of recoveries surged to over 11.86 lakh, according to the Union Health Ministry data. The number of COVID-19 tests carried out in India has also crossed the 2 crore-mark, according to the Indian Council of Medical Research (ICMR).
The total coronavirus cases surged to 18,03,695, while the death toll due to COVID-19 climbed to 38,135 with 771 people succumbing to the disease in a day, the data updated at 8 am showed.
There are 5,79,357 active cases of coronavirus infection in the country at present while the recoveries have increased to 11,86,203.
Frequently Asked Questions
A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.
There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.
Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
The COVID-19 recovery rate stands at 65.44 percent, while the fatality rate is at 2.13 per cent, the data stated. The total number of confirmed cases also includes foreigners.
This is the fifth consecutive day that COVID-19 cases have increased by more than 50,000 in the country. India's COVID-19 tally had crossed the 17-lakh mark on Sunday.
According to the ICMR, a cumulative total of 2,02,02,858 samples have been tested up to August 2 with 3,81,027 samples being tested on Sunday.Click here for Moneycontrol's full coverage of the COVID-19 outbreak